• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炭疽芽孢杆菌保护性抗原C端免疫显性B细胞表位的鉴定与特性分析

Identification and characterization of immunodominant B-cell epitope of the C-terminus of protective antigen of Bacillus anthracis.

作者信息

Kaur Manpreet, Chug Hema, Singh Harpreet, Chandra Subhash, Mishra Manish, Sharma Meenakshi, Bhatnagar Rakesh

机构信息

Laboratory of Molecular Biology and Genetic Engineering, School of Biotechnology, Jawaharlal Nehru University, New Delhi 110067, Delhi, India.

出版信息

Mol Immunol. 2009 Jun;46(10):2107-15. doi: 10.1016/j.molimm.2008.12.031. Epub 2009 Apr 7.

DOI:10.1016/j.molimm.2008.12.031
PMID:19356802
Abstract

Bacillus anthracis is the etiological agent of anthrax. Protective antigen (PA) has been established as the key protective immunogen and is the major component of anthrax vaccine. Prior studies have indicated that C-terminus host cell receptor binding region contains dominant protective epitopes of PA. In the present study, we focused our attention on determining B-cell epitopes from this region, which could be employed as a vaccine. Using B-cell epitope prediction systems, three regions were identified; ID-I: 604-622, ID-II: 626-676 and ID-III: 707-723 aa residues. These epitopes elicited potent B-cell response in BALB/c mice. ID-II in particular was found to be highly immunogenic in terms of IgG antibody titre, with a predominantly IgG1/IgG2a subclass distribution indicating Th2 bias and high affinity/avidity index. Effective cellular immunity was additionally generated which also signified its Th2 bias. Further, ID-II induced high level of lethal toxin neutralizing antibodies and robust protective immunity (66%) against in vivo lethal toxin challenge. Thus, ID-II can be classified as an immunodominant B-cell epitope and may prove significant in the development of an effective immunoprophylactic strategy against anthrax.

摘要

炭疽芽孢杆菌是炭疽病的病原体。保护性抗原(PA)已被确立为关键的保护性免疫原,是炭疽疫苗的主要成分。先前的研究表明,C末端宿主细胞受体结合区域包含PA的主要保护性表位。在本研究中,我们重点关注确定该区域可作为疫苗使用的B细胞表位。使用B细胞表位预测系统,确定了三个区域;ID-I:604-622,ID-II:626-676和ID-III:707-723个氨基酸残基。这些表位在BALB/c小鼠中引发了强烈的B细胞反应。特别是ID-II,就IgG抗体滴度而言具有高度免疫原性,其主要为IgG1/IgG2a亚类分布,表明存在Th2偏向以及高亲和力/亲合力指数。此外还产生了有效的细胞免疫,这也表明其存在Th2偏向。此外,ID-II诱导产生了高水平的致死毒素中和抗体以及针对体内致死毒素攻击的强大保护性免疫(66%)。因此,ID-II可被归类为免疫显性B细胞表位,可能在开发针对炭疽的有效免疫预防策略中具有重要意义。

相似文献

1
Identification and characterization of immunodominant B-cell epitope of the C-terminus of protective antigen of Bacillus anthracis.炭疽芽孢杆菌保护性抗原C端免疫显性B细胞表位的鉴定与特性分析
Mol Immunol. 2009 Jun;46(10):2107-15. doi: 10.1016/j.molimm.2008.12.031. Epub 2009 Apr 7.
2
Identifying B and T cell epitopes and studying humoral, mucosal and cellular immune responses of peptides derived from V antigen of Yersinia pestis.鉴定鼠疫耶尔森菌V抗原衍生肽的B细胞和T细胞表位,并研究其体液免疫、黏膜免疫和细胞免疫反应。
Vaccine. 2008 Jan 17;26(3):316-32. doi: 10.1016/j.vaccine.2007.11.028. Epub 2007 Dec 3.
3
Passive vaccination with a human monoclonal antibody: generation of antibodies and studies for efficacy in Bacillus anthracis infections.被动免疫接种人源单克隆抗体:抗炭疽芽孢杆菌感染的抗体产生和功效研究。
Immunobiology. 2011 Jul;216(7):847-53. doi: 10.1016/j.imbio.2010.12.001. Epub 2010 Dec 10.
4
The 2beta2-2beta3 loop of anthrax protective antigen contains a dominant neutralizing epitope.炭疽保护性抗原的2β2 - 2β3环包含一个主要的中和表位。
Biochem Biophys Res Commun. 2006 Mar 24;341(4):1164-71. doi: 10.1016/j.bbrc.2006.01.080. Epub 2006 Jan 26.
5
Deletion modification enhances anthrax specific immunity and protective efficacy of a hepatitis B core particle-based anthrax epitope vaccine.缺失修饰增强了基于乙肝核心颗粒的炭疽表位疫苗的炭疽特异性免疫和保护效力。
Immunobiology. 2014 Feb;219(2):97-103. doi: 10.1016/j.imbio.2013.08.008. Epub 2013 Aug 23.
6
[Monoclonal antibodies to B.anthracis protective antigen are capable to neutralize and to enhance the anthrax lethal toxin action in vitro].针对炭疽杆菌保护性抗原的单克隆抗体在体外能够中和并增强炭疽致死毒素的作用。
Mol Gen Mikrobiol Virusol. 2004(3):21-6.
7
Stochastic humoral immunity to Bacillus anthracis protective antigen: identification of anti-peptide IgG correlating with seroconversion to Lethal Toxin neutralization.炭疽芽孢杆菌保护性抗原体液免疫的随机性:与致死毒素中和抗体血清转阳相关的抗肽 IgG 的鉴定。
Vaccine. 2013 Apr 3;31(14):1856-63. doi: 10.1016/j.vaccine.2013.01.040. Epub 2013 Feb 13.
8
Plasmid-based vaccination with candidate anthrax vaccine antigens induces durable type 1 and type 2 T-helper immune responses.基于质粒的候选炭疽疫苗抗原接种可诱导持久的1型和2型辅助性T细胞免疫反应。
Vaccine. 2008 Jan 30;26(5):614-22. doi: 10.1016/j.vaccine.2007.11.072. Epub 2007 Dec 18.
9
Sequential B-cell epitopes of Bacillus anthracis lethal factor bind lethal toxin-neutralizing antibodies.炭疽杆菌致死因子的连续B细胞表位与致死毒素中和抗体结合。
Infect Immun. 2009 Jan;77(1):162-9. doi: 10.1128/IAI.00788-08. Epub 2008 Nov 3.
10
[Toxin-neutralizing monoclonal antibodies to the different domains of anthrax protective antigen].针对炭疽保护性抗原不同结构域的毒素中和单克隆抗体
Wei Sheng Wu Xue Bao. 2005 Dec;45(6):947-51.

引用本文的文献

1
Proteome-Wide Identification and Comparison of Drug Pockets for Discovering New Drug Indications and Side Effects.全蛋白质组范围鉴定和比较药物口袋以发现新的药物适应症和副作用
Molecules. 2025 Jan 10;30(2):260. doi: 10.3390/molecules30020260.
2
Computational Methods to Predict Conformational B-Cell Epitopes.计算方法预测构象 B 细胞表位。
Biomolecules. 2024 Aug 10;14(8):983. doi: 10.3390/biom14080983.
3
A Bivalent Protein r-PAbxpB Comprising PA Domain IV and Exosporium Protein BxpB Confers Protection Against Spores and Toxin.
一种包含 PA 结构域 IV 和外孢子蛋白 BxpB 的二价蛋白 r-PAbxpB 可提供针对孢子和毒素的保护。
Front Immunol. 2019 Mar 19;10:498. doi: 10.3389/fimmu.2019.00498. eCollection 2019.
4
Development of a novel multiepitope chimeric vaccine against anthrax.开发一种针对炭疽病的新型多表位嵌合疫苗。
Med Microbiol Immunol. 2019 Apr;208(2):185-195. doi: 10.1007/s00430-019-00577-x. Epub 2019 Jan 22.
5
A bivalent protein r-PB, comprising PA and BclA immunodominant regions for comprehensive protection against Bacillus anthracis.一种双价蛋白 r-PB,包含 PA 和 BclA 免疫优势区,可全面预防炭疽杆菌。
Sci Rep. 2018 May 8;8(1):7242. doi: 10.1038/s41598-018-25502-9.
6
Th2-biased immune response and agglutinating antibodies generation by a chimeric protein comprising OmpC epitope (323-336) of Aeromonas hydrophila and LTB.由包含气单胞菌 OmpC 表位(323-336)和 LTB 的嵌合蛋白诱导的 Th2 偏向性免疫应答和凝集抗体产生。
Immunol Res. 2018 Feb;66(1):187-199. doi: 10.1007/s12026-017-8953-8.
7
Benchmarking B-cell epitope prediction with quantitative dose-response data on antipeptide antibodies: towards novel pharmaceutical product development.利用抗肽抗体的定量剂量反应数据对B细胞表位预测进行基准测试:迈向新型药品开发
Biomed Res Int. 2014;2014:867905. doi: 10.1155/2014/867905. Epub 2014 May 11.
8
A single-dose PLGA encapsulated protective antigen domain 4 nanoformulation protects mice against Bacillus anthracis spore challenge.一种单剂量 PLGA 包封保护性抗原结构域 4 纳米制剂可保护小鼠免受炭疽芽孢杆菌孢子的攻击。
PLoS One. 2013 Apr 29;8(4):e61885. doi: 10.1371/journal.pone.0061885. Print 2013.
9
Stochastic humoral immunity to Bacillus anthracis protective antigen: identification of anti-peptide IgG correlating with seroconversion to Lethal Toxin neutralization.炭疽芽孢杆菌保护性抗原体液免疫的随机性:与致死毒素中和抗体血清转阳相关的抗肽 IgG 的鉴定。
Vaccine. 2013 Apr 3;31(14):1856-63. doi: 10.1016/j.vaccine.2013.01.040. Epub 2013 Feb 13.
10
MHC class II and non-MHC class II genes differentially influence humoral immunity to Bacillus anthracis lethal factor and protective antigen.MHC 类 II 基因和非 MHC 类 II 基因对炭疽致死因子和保护性抗原的体液免疫有不同影响。
Toxins (Basel). 2012 Dec;4(12):1451-67. doi: 10.3390/toxins4121451.